MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,007 | -83.6% | 5,094 | -77.9% | 0.00% | -100.0% |
| Q2 2023 | $249,878 | -30.5% | 23,009 | -55.8% | 0.00% | 0.0% |
| Q1 2023 | $359,442 | +3485.1% | 52,093 | +1968.0% | 0.00% | – |
| Q4 2022 | $10,026 | -87.3% | 2,519 | -78.9% | 0.00% | – |
| Q3 2022 | $79,000 | +113.5% | 11,912 | +56.5% | 0.00% | – |
| Q2 2022 | $37,000 | -83.5% | 7,612 | -68.3% | 0.00% | – |
| Q1 2022 | $224,000 | -42.0% | 23,977 | -26.2% | 0.00% | – |
| Q4 2021 | $386,000 | +33.6% | 32,477 | +27.9% | 0.00% | – |
| Q3 2021 | $289,000 | +5680.0% | 25,387 | +9855.7% | 0.00% | – |
| Q2 2021 | $5,000 | -97.8% | 255 | -98.3% | 0.00% | – |
| Q1 2021 | $227,000 | -40.1% | 14,691 | -52.7% | 0.00% | -100.0% |
| Q4 2020 | $379,000 | +0.8% | 31,056 | +6.1% | 0.00% | 0.0% |
| Q3 2020 | $376,000 | – | 29,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |